Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys

Nuclear Medicine and Biology

Volumn 34, Issue 6, 2007, Pages 603-608

  Müller, Cristina ^a   Schibli, Roger ^b,c   Forrer, Flavio ^a   Krenning, Eric P ^a   de Jong, Marion ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ETH Zurich   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

5 methyl tetrahydrofolate; 99mTc radiofolate; Antifolate; Folate receptor; Folic acid; Pemetrexed

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; FOLIC ACID; PEMETREXED; PICOLYLAMINE MONOACETIC ACID FOLATE TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; KIDNEY TUMOR; MOUSE; NONHUMAN; NUDE MOUSE; RADIATION DETECTION; TISSUE DISTRIBUTION; XENOGRAFT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; FOLIC ACID ANTAGONISTS; HUMANS; KB CELLS; KIDNEY; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TETRAHYDROFOLATES; TISSUE DISTRIBUTION;

EID: 34547830383     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.06.001     Document Type: Article

References (37)

1. Leamon C.P., and Low P.S. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today 6 (2001) 44-51
2. Ke C.Y., Mathias C.J., and Green M.A. The folate receptor as a molecular target for tumor-selective radionuclide delivery. Nucl Med Biol 30 (2003) 811-817
3. Ke C.Y., Mathias C.J., and Green M.A. Folate-receptor-targeted radionuclide imaging agents. Adv Drug Deliv Rev 56 (2004) 1143-1160
4. Konda S.D., Aref M., Wang S., Brechbiel M., and Wiener E.C. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. MAGMA 12 (2001) 104-113
5. Leamon C.P., and Reddy J.A. Folate-targeted chemotherapy. Adv Drug Deliv Rev 56 (2004) 1127-1141
6. Zhao X.B.B., and Lee R.J. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev 56 (2004) 1193-1204
7. Leamon C.P., and Low P.S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci U S A 88 (1991) 5572-5576
8. Ward C.M., Acheson N., and Seymour L.W. Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients. J Drug Target 8 (2000) 119-123
9. Kranz D.R., Manning T.C., Rund L.A., Cho B.K., Gruber M.M., and Roy E.J. Targeting tumor cells with bispecific antibodies and T cells. J Control Release 53 (1998) 77-84
10. Roy E.J., Gawlick U., Orr B.A., and Kranz D.M. Folate-mediated targeting of T cells to tumors. Adv Drug Deliv Rev 56 (2004) 1219-1231
11. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M.M., et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem 10 (1999) 289-298
12. Gabizon A., Shmeeda H., Horowitz A.T., and Zalipsky S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev 56 (2004) 1177-1192
13. Nakashima-Matsushita N., Homma T., Yu S., Matsuda T., Sunahara N., Nakamura T., et al. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 42 (1999) 1609-1616
14. Turk M.J., Breur G.J., Widmer W.R., Paulos C.M., Xu L.C., Grote L.A., et al. Foliate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum 46 (2002) 1947-1955
15. Paulos C.M., Turk M.J., Breur G.J., and Low P.S. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 56 (2004) 1205-1217
16. 99mTc-technetium(I)- and Re-rhenium(I)-folate derivatives for potential use in nuclear medicine. J Organomet Chem 689 (2004) 4712-4721
17. 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting. Eur J Nucl Med Mol Imaging 33 (2006) 1007-1016
18. 3-folates. Bioconjugate Chem 17 (2006) 797-806
19. + and synthesis of tailor-made bifunctional ligand systems. Bioconjugate Chem 13 (2002) 750-756
20. 188Re: a potential strategy for diagnosis and therapy of folate receptor positive tumors. Nucl Med Biol 34 (2007) 595-601
21. Goresky C.A., Watanabe H., and Johns D.G. Renal excretion of folic acid. J Clin Invest 42 (1963) 1841
22. Birn H., Spiegelstein O., Christensen E.I., and Finnell R.H. Renal tubular reabsorption of folate mediated by folate binding protein 1. J Am Soc Nephrol 16 (2005) 608-615
23. 12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins. Am J Physiol Renal Physiol 291 (2006) F22-F36
24. Müller C., Brühlmeier M., Schubiger A.P., and Schibli R. Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo. J Nucl Med 47 (2006) 2057-2064
25. +. J Am Chem Soc 123 (2001) 3135-3136
26. Antony A.C., Kane M.A., Portillo R.M., Elwood P.C., and Kolhouse J.F. Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J Biol Chem 260 (1985) 4911-4917
27. Mathias C.J., Wang S., Lee R.J., Waters D.J., Low P.S., and Green M.A. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med 37 (1996) 1003-1008
28. Huennekens F.M. The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul 34 (1994) 397-419
29. Jackman A.L., Theti D.S., and Gibbs D.D. Antifolates targeted specifically to the folate receptor. Adv Drug Deliv Rev 56 (2004) 1111-1125
30. Westerhof G.R., Jansen G., Vanemmerik N., Kathmann I., Rijksen G., Jackman A.L., et al. Membrane-transport of natural folates and antifolate compounds in murine L1210 leukemia-cells - role of carrier-mediated and receptor-mediated transport-systems. Cancer Res 51 (1991) 5507-5513
31. Westerhof G.R., Schornagel J.H., Kathmann I., Jackman A.L., Rosowsky A., Forsch R.A., et al. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular structure and biological activity. Mol Pharmacol 48 (1995) 459-471
32. Paz-Ares L., Bezares S., Tabernero J.M., Castellanos D., and Cortes-Funes H. Review of a promising new agent - pemetrexed disodium. Cancer 97 (2003) 2056-2063
33. Hanauske A.R., Chen V., Paoletti P., and Niyikiza C. Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors. Oncologist 6 (2001) 363-373
34. Dawson N.J. The surface area/body-weight relationship in mice. Aust J Biol Sci 20 (1967) 687-690
35. Worzalla J.F., Shih C., and Schultz R.M. Role of folic acid in modulating the toxicity and efficacy of the multitargeted antifolate, LY231514. Anticancer Res 18 (1998) 3235-3239
36. Teicher B.A., Chen V., Shih C., Menon K., Forler P.A., Phares V.G., et al. Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts. Clin Cancer Res 6 (2000) 1016-1023
37. van der Wilt C.L., Backus H.H.J., Smid K., Comijn L., Veerman G., Wouters D., et al. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. Cancer Res 61 (2001) 3675-3681